zyrtec cetirizine hydrochloride 5 mg chewable tablet blister pack (general sale)
johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 5 mg - tablet, chewable - excipient ingredients: betadex; lactose monohydrate; silicified microcrystalline cellulose; sucralose; magnesium stearate; maize starch; mannitol; flavour - seasonal allergic rhinitis: relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 6 years & over. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes.
metadex xr 10 mg
k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 10 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.
metadex xr 15 mg
k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 15 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.
metadex xr 30 mg
k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 30 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.
metadex xr 40 mg
k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 40 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.
metadex xr 5 mg
k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 5 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.
perindopril/indapamide 4mg/ 1.25mg tablets
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - perindopril tert, butylamine salt, indapamide - tablet - perindopril tert-butylamine salt 4 mg indapamide 1.25 mg - agents acting on the renin-angiotensin system
miramel 0.088 mg tablets
clonmel healthcare ltd - pramipexole - tablet - 0.088 milligram(s) - dopamine agonists; pramipexole
miramel 0.18 mg tablets
clonmel healthcare ltd - pramipexole - tablet - 0.18 milligram(s) - dopamine agonists; pramipexole
miramel 0.7 mg tablets
clonmel healthcare ltd - pramipexole - tablet - 0.7 milligram(s) - dopamine agonists; pramipexole